HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mauro Martins Teixeira Selected Research

Met- RANTES

2/2009The chemokine CCL5 is essential for leukocyte recruitment in a model of severe Herpes simplex encephalitis.
3/2007Trypanosoma cruzi-triggered meningoencephalitis is a CCR1/CCR5-independent inflammatory process.
9/2004Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mauro Martins Teixeira Research Topics

Disease

52Inflammation (Inflammations)
10/2022 - 03/2007
47Infections
06/2022 - 08/2004
12Arthritis (Polyarthritis)
10/2022 - 08/2004
9Chagas Disease (American Trypanosomiasis)
11/2021 - 04/2007
8Neoplasms (Cancer)
08/2022 - 02/2010
8Necrosis
01/2020 - 09/2009
8Fibrosis (Cirrhosis)
01/2019 - 04/2007
6Pneumonia (Pneumonitis)
06/2022 - 01/2013
6Bone Resorption
03/2016 - 01/2010
5Ischemia
11/2022 - 07/2008
5Gout
10/2022 - 08/2015
4Mucositis
08/2022 - 05/2012
4Communicable Diseases (Infectious Diseases)
02/2022 - 12/2013
4COVID-19
01/2022 - 01/2021
4Virus Diseases (Viral Diseases)
01/2019 - 07/2010
4Brain Ischemia (Cerebral Ischemia)
01/2017 - 01/2013
4Parasitemia
05/2016 - 08/2010
4Periodontal Diseases (Periodontal Disease)
11/2014 - 01/2012
3Dengue (Dengue Fever)
01/2022 - 09/2013
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 11/2017
3Reperfusion Injury
05/2021 - 07/2008
3Disease Progression
01/2021 - 07/2012
3Asthma (Bronchial Asthma)
01/2021 - 01/2020
3Fatigue
01/2021 - 04/2013
3Zika Virus Infection
01/2021 - 01/2017
3Obesity
01/2020 - 02/2016
3Silicosis
12/2019 - 05/2014
3Chemical and Drug Induced Liver Injury
12/2019 - 01/2015
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2019 - 03/2016
3Glucose Intolerance
01/2018 - 01/2014
3Cerebral Malaria
11/2017 - 01/2015
3Chronic Renal Insufficiency
04/2017 - 07/2011
3Ischemic Stroke
01/2017 - 01/2013
3Sepsis (Septicemia)
01/2016 - 01/2015
3Leprosy (Hansen's Disease)
12/2013 - 01/2008
3Herpes Simplex Encephalitis (Herpes Encephalitis)
02/2013 - 11/2008
3Alveolar Bone Loss
07/2012 - 10/2011
2Edema (Dropsy)
10/2021 - 11/2010
2Paracoccidioidomycosis (South American Blastomycosis)
01/2021 - 01/2013
2Wounds and Injuries (Trauma)
01/2021 - 07/2010
2Respiratory Hypersensitivity
01/2020 - 08/2016
2Neuroinflammatory Diseases
01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

34CytokinesIBA
06/2022 - 01/2008
19ChemokinesIBA
06/2022 - 08/2004
13AntigensIBA
10/2022 - 07/2012
11Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2012
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 09/2009
9angiotensin I (1-7)IBA
02/2022 - 04/2007
9Interleukin-6 (Interleukin 6)IBA
10/2021 - 04/2012
8CollagenIBA
01/2021 - 08/2010
8Messenger RNA (mRNA)IBA
01/2020 - 03/2007
6InterleukinsIBA
01/2022 - 05/2014
6Biomarkers (Surrogate Marker)IBA
01/2019 - 02/2010
5Annexin A1IBA
02/2022 - 01/2016
5Interferon-gamma (Interferon, gamma)IBA
12/2021 - 08/2014
5Peptides (Polypeptides)IBA
01/2021 - 08/2015
5platelet activating factor receptorIBA
01/2020 - 01/2013
5Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
01/2020 - 08/2010
5EnzymesIBA
07/2018 - 08/2010
5Interleukin-17 (Interleukin 17)IBA
01/2018 - 01/2012
5Platelet Activating FactorIBA
12/2016 - 01/2013
4DNA (Deoxyribonucleic Acid)IBA
08/2022 - 01/2015
4Interleukin-12 (IL 12)IBA
10/2021 - 01/2010
4Caspase 3 (Caspase-3)IBA
01/2021 - 04/2012
4VaccinesIBA
01/2020 - 09/2015
4Interleukin-10 (Interleukin 10)IBA
01/2020 - 05/2014
4Acetaminophen (Paracetamol)FDA LinkGeneric
12/2018 - 01/2014
4CC ChemokinesIBA
01/2017 - 09/2004
4Chemokine CCL5IBA
02/2009 - 08/2004
3Immunoglobulin G (IgG)IBA
11/2022 - 01/2014
3Uric Acid (Urate)IBA
10/2022 - 08/2015
3LigandsIBA
08/2022 - 09/2009
3Monoclonal AntibodiesIBA
01/2022 - 01/2015
3Antiviral Agents (Antivirals)IBA
01/2022 - 01/2021
3Oxygen (Dioxygen)IBA
05/2021 - 07/2008
3AntioxidantsIBA
05/2021 - 03/2016
3Pharmaceutical PreparationsIBA
01/2021 - 01/2014
3OvalbuminIBA
01/2021 - 02/2016
3InterferonsIBA
01/2020 - 02/2011
3CarbohydratesIBA
05/2019 - 09/2015
3Type I Tumor Necrosis Factor ReceptorsIBA
01/2018 - 07/2010
3Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2018 - 02/2011
3Leukotriene B4IBA
11/2017 - 08/2004
3LipidsIBA
01/2017 - 08/2010
3Chemokine ReceptorsIBA
05/2016 - 07/2010
3AutoantibodiesIBA
11/2010 - 04/2007
3Met- RANTESIBA
02/2009 - 09/2004
2Aconitic Acid (Aconitate)IBA
10/2022 - 03/2018
2Irinotecan (Camptosar)FDA LinkGeneric
08/2022 - 01/2016
2Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
11/2021 - 01/2020
2lipoxin A4IBA
11/2021 - 01/2020
2Interleukin-1beta (Interleukin 1 beta)IBA
10/2021 - 01/2008
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021 - 05/2016
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2018
2Ethanol (Ethyl Alcohol)IBA
01/2020 - 03/2016

Therapy/Procedure

20Therapeutics
02/2022 - 07/2008
5Drug Therapy (Chemotherapy)
08/2022 - 02/2010
4Oral Administration
01/2021 - 02/2018
3Aftercare (After-Treatment)
01/2019 - 02/2010
2Hematopoietic Stem Cell Transplantation
01/2022 - 05/2012